Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Meta-analysis of the DRD5 VNTR in persistent ADHD.

Klein M, Berger S, Hoogman M, Dammers J, Makkinje R, Heister AJ, Galesloot TE, Kiemeney LA, Weber H, Kittel-Schneider S, Lesch KP, Reif A, Ribasés M, Ramos-Quiroga JA, Cormand B, Zayats T, Hegvik TA, Jacobsen KK, Johansson S, Haavik J, Mota NR, Bau CH, Grevet EH, Doyle A, Faraone SV, Arias-Vásquez A, Franke B.

Eur Neuropsychopharmacol. 2016 Jul 29. pii: S0924-977X(16)30096-7. doi: 10.1016/j.euroneuro.2016.06.012. [Epub ahead of print]

PMID:
27480019
2.

Brain abnormalities in adults with Attention Deficit Hyperactivity Disorder revealed by voxel-based morphometry.

Moreno-Alcázar A, Ramos-Quiroga JA, Radua J, Salavert J, Palomar G, Bosch R, Salvador R, Blanch J, Casas M, McKenna PJ, Pomarol-Clotet E.

Psychiatry Res. 2016 Aug 30;254:41-7. doi: 10.1016/j.pscychresns.2016.06.002. Epub 2016 Jun 9.

PMID:
27318593
3.

Criteria and Concurrent Validity of DIVA 2.0: A Semi-Structured Diagnostic Interview for Adult ADHD.

Ramos-Quiroga JA, Nasillo V, Richarte V, Corrales M, Palma F, Ibáñez P, Michelsen M, Van de Glind G, Casas M, Kooij JJ.

J Atten Disord. 2016 Apr 28. pii: 1087054716646451. [Epub ahead of print]

PMID:
27125994
4.

Cortisol awakening response in adults with attention deficit hyperactivity disorder: Subtype differences and association with the emotional lability.

Ramos-Quiroga JA, Corominas-Roso M, Palomar G, Ferrer R, Valero S, Corrales M, Richarte V, Casas M.

Eur Neuropsychopharmacol. 2016 Jul;26(7):1140-9. doi: 10.1016/j.euroneuro.2016.03.014. Epub 2016 Apr 12.

PMID:
27084305
5.

Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium.

Stringer S, Minică CC, Verweij KJ, Mbarek H, Bernard M, Derringer J, van Eijk KR, Isen JD, Loukola A, Maciejewski DF, Mihailov E, van der Most PJ, Sánchez-Mora C, Roos L, Sherva R, Walters R, Ware JJ, Abdellaoui A, Bigdeli TB, Branje SJ, Brown SA, Bruinenberg M, Casas M, Esko T, Garcia-Martinez I, Gordon SD, Harris JM, Hartman CA, Henders AK, Heath AC, Hickie IB, Hickman M, Hopfer CJ, Hottenga JJ, Huizink AC, Irons DE, Kahn RS, Korhonen T, Kranzler HR, Krauter K, van Lier PA, Lubke GH, Madden PA, Mägi R, McGue MK, Medland SE, Meeus WH, Miller MB, Montgomery GW, Nivard MG, Nolte IM, Oldehinkel AJ, Pausova Z, Qaiser B, Quaye L, Ramos-Quiroga JA, Richarte V, Rose RJ, Shin J, Stallings MC, Stiby AI, Wall TL, Wright MJ, Koot HM, Paus T, Hewitt JK, Ribasés M, Kaprio J, Boks MP, Snieder H, Spector T, Munafò MR, Metspalu A, Gelernter J, Boomsma DI, Iacono WG, Martin NG, Gillespie NA, Derks EM, Vink JM.

Transl Psychiatry. 2016 Mar 29;6:e769. doi: 10.1038/tp.2016.36.

6.

Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder.

Brevik EJ, van Donkelaar MM, Weber H, Sánchez-Mora C, Jacob C, Rivero O, Kittel-Schneider S, Garcia-Martínez I, Aebi M, van Hulzen K, Cormand B, Ramos-Quiroga JA; IMAGE Consortium, Lesch KP, Reif A, Ribasés M, Franke B, Posserud MB, Johansson S, Lundervold AJ, Haavik J, Zayats T.

Am J Med Genet B Neuropsychiatr Genet. 2016 Jul;171(5):733-47. doi: 10.1002/ajmg.b.32434. Epub 2016 Mar 29.

PMID:
27021288
7.

Connecting the dots, genome-wide association studies in substance use.

Nivard MG, Verweij KJ, Minică CC, Treur JL; International Cannabis Consortium, Vink JM, Boomsma DI.

Mol Psychiatry. 2016 Jun;21(6):733-5. doi: 10.1038/mp.2016.14. Epub 2016 Mar 15. No abstract available.

PMID:
26976040
8.

Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers.

Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MW, Demetrovics Z, Kapitány-Fövény M, Schoevers RA, van Emmerik-van Oortmerssen K, Carpentier PJ, Dom G, Verspreet S, Crunelle CL, Young JT, Carruthers S, Cassar J, Fatséas M, Auriacombe M, Johnson B, Dunn M, Slobodin O, van den Brink W.

J Atten Disord. 2016 Feb 27. pii: 1087054716629217. [Epub ahead of print]

PMID:
26922805
9.

Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.

Newcorn JH, Harpin V, Huss M, Lyne A, Sikirica V, Johnson M, Ramos-Quiroga JA, van Stralen J, Dutray B, Sreckovic S, Bloomfield R, Robertson B.

J Child Psychol Psychiatry. 2016 Jun;57(6):717-28. doi: 10.1111/jcpp.12492. Epub 2016 Feb 12.

PMID:
26871297
10.

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.

Pagerols M, Richarte V, Sánchez-Mora C, Garcia-Martínez I, Corrales M, Corominas M, Cormand B, Casas M, Ribasés M, Ramos-Quiroga JA.

Pharmacogenomics J. 2016 Jan 26. doi: 10.1038/tpj.2015.89. [Epub ahead of print]

PMID:
26810137
11.

Functional Imaging Changes in the Medial Prefrontal Cortex in Adult ADHD.

Salavert J, Ramos-Quiroga JA, Moreno-Alcázar A, Caseras X, Palomar G, Radua J, Bosch R, Salvador R, McKenna PJ, Casas M, Pomarol-Clotet E.

J Atten Disord. 2015 Oct 29. pii: 1087054715611492. [Epub ahead of print]

PMID:
26515892
12.

Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe.

Deberdt W, Thome J, Lebrec J, Kraemer S, Fregenal I, Ramos-Quiroga JA, Arif M.

BMC Psychiatry. 2015 Oct 13;15:242. doi: 10.1186/s12888-015-0624-5.

13.

Family Functioning and Parental Bonding During Childhood in Adults Diagnosed With ADHD.

Montejo JE, Durán M, Del Mar Martínez M, Hilari A, Roncalli N, Vilaregut A, Corrales M, Nogueira M, Casas M, Linares JL, Ramos-Quiroga JA.

J Atten Disord. 2015 Aug 24. pii: 1087054715596578. [Epub ahead of print]

PMID:
26306796
14.

Clinical, Psychopathological, and Personality Characteristics Associated with ADHD among Individuals Seeking Treatment for Gambling Disorder.

Aymamí N, Jiménez-Murcia S, Granero R, Ramos-Quiroga JA, Fernández-Aranda F, Claes L, Sauvaget A, Grall-Bronnec M, Gómez-Peña M, Savvidou LG, Fagundo AB, del Pino-Gutierrez A, Moragas L, Casas M, Penelo E, Menchón JM.

Biomed Res Int. 2015;2015:965303. doi: 10.1155/2015/965303. Epub 2015 Jul 1.

15.

New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder.

Alemany S, Ribasés M, Vilor-Tejedor N, Bustamante M, Sánchez-Mora C, Bosch R, Richarte V, Cormand B, Casas M, Ramos-Quiroga JA, Sunyer J.

Am J Med Genet B Neuropsychiatr Genet. 2015 Jul 14. doi: 10.1002/ajmg.b.32341. [Epub ahead of print]

PMID:
26174813
16.

Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder.

Sánchez-Mora C, Richarte V, Garcia-Martínez I, Pagerols M, Corrales M, Bosch R, Vidal R, Viladevall L, Casas M, Cormand B, Ramos-Quiroga JA, Ribasés M.

Am J Med Genet B Neuropsychiatr Genet. 2015 Jul 14. doi: 10.1002/ajmg.b.32340. [Epub ahead of print]

PMID:
26174753
17.

On the role of NOS1 ex1f-VNTR in ADHD-allelic, subgroup, and meta-analysis.

Weber H, Kittel-Schneider S, Heupel J, Weißflog L, Kent L, Freudenberg F, Alttoa A, Post A, Herterich S, Haavik J, Halmøy A, Fasmer OB, Landaas ET, Johansson S, Cormand B, Ribasés M, Sánchez-Mora C, Ramos-Quiroga JA, Franke B, Lesch KP, Reif A.

Am J Med Genet B Neuropsychiatr Genet. 2015 Jun 18. doi: 10.1002/ajmg.b.32326. [Epub ahead of print]

PMID:
26086921
18.

Bipolar disorder with comorbid attention-deficit and hyperactivity disorder. Main clinical features and clues for an accurate diagnosis.

Torres I, Gómez N, Colom F, Jiménez E, Bosch R, Bonnín CM, Martínez-Aran A, Casas M, Vieta E, Ramos-Quiroga JA, Goikolea JM.

Acta Psychiatr Scand. 2015 Nov;132(5):389-99. doi: 10.1111/acps.12426. Epub 2015 Apr 20.

PMID:
25900393
19.

Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study.

Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MW, van den Brink W, Moggi F; IASP Research Group.

Eur Addict Res. 2015;21(4):188-94. doi: 10.1159/000371724. Epub 2015 Apr 1.

20.

Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial.

Vidal R, Castells J, Richarte V, Palomar G, García M, Nicolau R, Lazaro L, Casas M, Ramos-Quiroga JA.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):275-82. doi: 10.1016/j.jaac.2014.12.016. Epub 2015 Jan 26.

PMID:
25791144
Items per page

Supplemental Content

Loading ...
Write to the Help Desk